Educational Objectives: By the end of the activity, participants will be able to:
1. Identify and apply the best treatment options for patients with neurovascular diseases (i.e aneurysms, AVM, DAVF, Moya-moya, carotid stenosis), using evidence-based practices and expert consensus. Provide recommendations for age-specific related treatment specific to the age and geriatric population as applicable.
2. Integrate cultural competency into the discussions that will assist in integrating the attitudes, evidence based treatment recommendations and skills that enables a health care professional to care effectively for patients from diverse cultures, groups and communities.
3. Transfer the evidence based treatment recommendations of individual practitioners through collaboration of case management.
Physician Focus: Neurosurgeons, Interventional Neuro- Radiologists. Interventional Radiologists, Neurointensivists, Neuroscience
Non-Physician Professionals: Neuroscience NP, Interventional Neuro NP, Stroke Coordinator
Planners (varies): TBD
Speakers (Varies): TBD
1. AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage sahguidelines09.pdf
2. AHA/ASA Guidelines for the Prevention & Management of Stroke 2 CR_StrokeRecommendations_References_2015_Final.pdf
3. The New England Journal of Medicine, A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke,January 1, 2015, N Engl J Med 2015;372:11-20. DOI: 10.1056/NEJMoa1411587 3 ESTMRCLEAN.pdf
4. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383:614 –21 Mohr JP, Parides MK, Stapf C, et al.
5. International Study of Unruptured Intracranial Aneurysms (ISUIA), Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment, THE LANCET • Vol 362 • July 12, 2003 5 lancetISUIA2003.pdf
6.Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the fi nal results of a randomised trial, Lancet 2014; 383: 333–41
Disclosure: The presenters and program planners of this conference have disclosed that he/she has no relevant financial relationships with commercial interest. The CME Department has reviewed their disclosure information for theplanner(s) and/or committee / faculty for this program and they do not have relationships that present a conflict of interest.
Kaiser Permanente Medical Center - Redwood City takes responsibility for the content , quality and scientific integrity of this CME Activity .
Kaiser Permanente does not endorse any brand -name products.
Kaiser Permanente Medical Center - Redwood City is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
The Kaiser Permanente Medical Center - Redwood City designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.